Urologists with Keck Medicine of USC have launched a clinical trial to perform the world’s first bladder transplant. The transplant would be a major step toward a potential new surgical option for hundreds of millions of people worldwide who experience various forms of bladder disease and dysfunction.
The trial is currently screening potential participants for this groundbreaking transplantation, which would be performed by Keck Medicine urologists using robotic surgery.
“Transplantation is a lifesaving treatment option for conditions affecting many major organs, and transplanting a bladder could be a historic step in improving lives,” said Inderbir Gill, MD, founding executive director of USC Urology, part of Keck Medicine. Gill is also the principal investigator of the clinical trial and leading the transplantation efforts.
“We could be on the verge of a medical advance that has the potential to revolutionize how we treat terminally compromised bladders.”
To read the full story, click here.